Integrated Quantum (CSE:ICS) Announces $1.5 Million Private Placement

Vancouver, British Columbia — February 24, 2026 — Leads & Copy — Integrated Cyber Solutions Inc. (CSE: ICS) (OTCQB: IGCRF) (FSE: Y4G), operating as Integrated Quantum Technologies, has announced a non-brokered private placement financing to raise $1,500,000.

The company will offer 1,500,000 common shares at a price of C$1.00 per share. The shares will be subject to a four-month hold period as per Canadian securities laws.

Integrated Quantum intends to allocate the net proceeds from the offering to general working capital and software development.

The offering is subject to customary closing conditions, including the submission of required forms to the Canadian Securities Exchange (CSE).

The company’s securities have not been registered under the U.S. Securities Act of 1933 or any U.S. state securities laws and may not be offered or sold in the United States without registration or an applicable exemption. This press release does not constitute an offer to sell or a solicitation of an offer to buy securities in any jurisdiction where such an offer, solicitation, or sale would be unlawful.

Integrated Quantum is focused on building quantum-ready infrastructure to secure and scale artificial intelligence. The company’s AIQu platform supports its product strategy for privacy-preserving and resilient AI systems. VEIL, its first product, protects sensitive AI data and workflows in enterprise environments. The company’s technologies address post-quantum security risks, increasing compute demands, and the complexities of deploying AI at scale.

Alan Guibord, Director & Chief Executive Officer of Integrated Cyber Solutions Inc. dba Integrated Quantum Technologies.

Source: Integrated Quantum

×

Welcome!

Biotech Reporter is the source most up-to-date real-time, direct-from-source News Tips and Story Leads.

By Subscribing you will receive Daily Biotech Update each day at 9:30 am ET (Market Open) in your inbox and you can unsubscribe any time.